FTA on pharmaceutical issues to resume in New York in Sept.

The pharmaceutical issue on the KORUS FTA talks that went failure during the recent 2nd meeting in Seoul seems to be resumed in the 3rd New York meeting in coming Sept.

The U. S. side insisted to scrap the positive list system raised by the Korean side under the NHI financial saving program in the name of "Drug price optimizing plan", claiming that the Korean government's new drug pricing sy...